全球泡腾产品市场 2023-2030
市场调查报告书
商品编码
1327647

全球泡腾产品市场 2023-2030

Global Effervescent Products Market 2023-2030

出版日期: | 出版商: Orion Market Research | 英文 157 Pages | 商品交期: 2-3个工作天内

价格

预计在预测期内(2023-2030年),全球泡腾产品市场将以7.51%的复合年增长率增长。泡腾产品经过专门设计,可快速溶解在液体中,促进身体快速吸收其活性成分。泡腾过程产生气泡溶液,有助于将产品分解成更小的颗粒,从而提高其溶解度和吸收率。泡腾产品的这一独特特性在市场上提供了几个关键优势,包括增强的生物利用度、符合不断增长的健康和保健趋势,以及为消费者提供可定制的选择和多种选择。

例如,2021年10月,Beneo推出的填充粘合剂GalenIQ 721。 GalenIQ 721 用作填充剂粘合剂,可增强泡腾片和粉末的风味和稠度。该赋形剂不吸湿、水溶性且可立即压缩,非常适合泡腾剂应用。其独特的性能确保泡腾产品製造过程中始终如一的高质量内容和生产效率。

目录

第 1 章:报告摘要

  • 当前行业分析及增长潜力展望
  • 研究方法和工具
  • 市场细分
    • 按细分
    • 按地区

第 2 章:市场概述和见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章:竞争格局

  • 主要公司分析
  • GSK plc
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Novartis AG
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Pfizer Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章:市场细分

  • 按产品形式分類的全球泡腾产品市场
    • 平板电脑
    • 指示
    • 颗粒剂
  • 按适应症分類的全球泡腾产品市场
    • 利尿剂
    • 疼痛管理
    • 胃病
    • 呼吸疾病
  • 按分销渠道分類的全球泡腾产品市场
    • 医院药房
    • 网上药房
    • 零售药房

第 5 章:区域分析

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 意大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章:公司简介

  • Alpex
  • Amerilab Technologies Inc.
  • Bliss GVS Pharma Ltd.
  • Bristol-Myers Squibb Co.
  • GlaxoSmithKline PLC
  • Herbalife Nutrition Ltd.
  • Hermes Arzneimittel
  • JW Nutritional Inc.
  • Nuun and Company Inc.
  • Paragon Laboratories
  • Pyramid Pharmaceuticals
  • S.G Biopharm pvt. Ltd
  • Swisse Wellness pty Ltd
  • Vitabiotics Ltd
  • Vovantis Laboratories Pvt. Ltd.
Product Code: OMR2027569

Title: Global Effervescent Products Market Size, Share & Trends Analysis Report by Product Form (Effervescent Tablets, Effervescent Powders, Effervescent Granules), by Indication (Diuretics, Pain Management, Gastric Disorders Respiratory Diseases), and by Distribution channel (Hospital Pharmacy, Online Pharmacy. Retail Pharmacy),Forecast Period (2023-2030).

The global effervescent products market is anticipated to grow at a CAGR of 7.51% during the forecast period (2023-2030). Effervescent products are specifically designed to dissolve quickly in fluids, facilitating the rapid absorption of their active ingredient by the body. The effervescence process creates a bubbly solution that aids in breaking down the product into smaller particles, thereby improving its solubility and absorption rate. This unique characteristic of effervescent products offers several key advantages in the market, including enhanced bioavailability, aligning with the rising health and wellness trends, and providing customizable options and a wide variety of choices for consumers.

For Instance, in October 2021, GalenIQ 721, a filler-binder that launched by Beneo. GalenIQ 721 serves as a filler-binder that enhances the flavor and consistency of effervescent tablets and powders. This excipient is non-hygroscopic, water-soluble, and immediately compressible, making it highly suitable for effervescent applications. Its unique properties ensure consistent high-quality content and production efficiency in the manufacturing of effervescent products.

With the increasing demand for efficient and fast-acting healthcare and wellness solutions, effervescent products are becoming a preferred choice for consumers. The ease of administration and improved absorption rate offered by these products are driving factors behind their popularity. As manufacturers continue to develop and introduce innovative excipients and formulations, the global effervescent product market is expected to witness sustained growth and widespread adoption in the coming years.

Segmental Outlook

The global effervescent products market is segmented on by product forms, by Indication, and by distribution channel. Based on the product forms, the market is sub-segmented into effervescent tablets, effervescent powders, effervescent granules. Based on the Indication, the market is sub-segmented into diuretics, pain management, gastric disorders respiratory diseases. Further, on the basis of distribution channel, the market is sub-segmented into hospital pharmacy, online pharmacy. retail pharmacy. Among the distribution channel, the online pharmacy sub-segment is anticipated to hold a considerable share of the market owing due to more emphasis is being placed on developing unique and appealing solutions. This development has caused online pharmacies, which provide consumers with accessible and convenient healthcare services, to soar in popularity.

The Effervescent Tablets Sub-Segment is Anticipated to Hold a Considerable Share of the Global Effervescent Products Market

Among the product form, the effervescent tablets sub-segment is expected to hold a considerable share of the global effervescent product market. Effervescent Tablets are a useful solution for people who have trouble swallowing regular pills or capsules. Due to it dissolve quickly in water and produce a pleasant and fizzy mouthfeel. Due to their availability in a wide range of formulations for use in nutritional supplements, medicines, personal care items, and other areas, effervescent tablets have a larger market potential and higher customer demand. For Instance, in January 2023, the growing UK-based pharmaceutical company Kelso Pharma has announced the launching of Acepiro (Acetylcysteine) 600mg effervescent tablets for the UK prescription medicine market as its maiden product launch.

Regional Outlook

The global effervescent tablets market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the high concentration of the market solution vendors including Pfizer Inc., GSK plc, Novartis AG, Perrigo Company plc, Reckitt Benckiser Group PLC and others.

The North America Region is Expected to Grow at a Significant CAGR in the Global Effervescent Products Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. The market expansion for effervescent products is being attributed to the increase in health consciousness among North American consumers. These products are sought after for their potential to improve wellness and provide benefits including immune support, hydration, and vitality. Consumers are looking for products to support their overall welding due to rising awareness of preventive healthcare, and Apparent Sent Formulations are meeting this desire. Key players in the effervescent product companies are present in the North American market, which benefits from their presence. New effervescent product lines are being aggressively introduced by pharmaceutical businesses to cater to the environment of customer demands.

Due to their distinct qualities and advantages, effervescent products are becoming more and more popular among consumers in North America. These products are formal letters that release bubbles when dissolved in water, creating the Fijian experience. They are frequently used in the pharmaceutical, personal care, and healthcare sectors. Effervescent tablets, powders, and granules are widely accessible and provide consumers with a convenient and simple to use option.

Market Players Outlook

The major companies serving the effervescent products market include: Pfizer Inc., GSK plc, Novartis AG, Perrigo Company plc, Reckitt Benckiser Group PLC, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For Instance, in February 2022, the Procter and Gamble company (P&G) launched boost vitamin, an Australian effervescent supplementary brand in measure retailers in Singapore. The product is available in seven SKUs and is sold in the nation's top pharmacies, supermarkets, and online retailers.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global effervescent products market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. GSK plc
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Novartis AG
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Pfizer Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Effervescent Products Market by Product Forms
    • 4.1.1. Tablets
    • 4.1.2. Indication
    • 4.1.3. Granules
  • 4.2. Global Effervescent Products Market by Indication
    • 4.2.1. Diuretics
    • 4.2.2. Pain Management
    • 4.2.3. Gastric Disorders
    • 4.2.4. Respiratory Diseases
  • 4.3. Global Effervescent Products Market by Distribution Channel
    • 4.3.1. Hospital Pharmacy
    • 4.3.2. Online Pharmacy
    • 4.3.3. Retail Pharmacy

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Alpex
  • 6.2. Amerilab Technologies Inc.
  • 6.3. Bliss GVS Pharma Ltd.
  • 6.4. Bristol-Myers Squibb Co.
  • 6.5. GlaxoSmithKline PLC
  • 6.6. Herbalife Nutrition Ltd.
  • 6.7. Hermes Arzneimittel
  • 6.8. JW Nutritional Inc.
  • 6.9. Nuun and Company Inc.
  • 6.10. Paragon Laboratories
  • 6.11. Pyramid Pharmaceuticals
  • 6.12. S.G Biopharm pvt. Ltd
  • 6.13. Swisse Wellness pty Ltd
  • 6.14. Vitabiotics Ltd
  • 6.15. Vovantis Laboratories Pvt. Ltd.

LIST OF TABLES

  • 1. GLOBAL EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY PRODUCT FORM, 2022-2030 ($ MILLION)
  • 2. GLOBAL EFFERVESCENT PRODUCTS AS TABLETS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL EFFERVESCENT PRODUCTS AS POWDER MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 4. GLOBAL EFFERVESCENT PRODUCTS AS GRANULES MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 5. GLOBAL EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
  • 6. GLOBAL EFFERVESCENT PRODUCTS FOR DIURETIC MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL EFFERVESCENT PRODUCTS FOR PAIN MANAGEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL EFFERVESCENT PRODUCTS FOR GASTRIC DISORDER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL EFFERVESCENT PRODUCTS FOR RESPIRATORY DISORDER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 11. GLOBAL EFFERVESCENT PRODUCTS BY HOSPITAL PHARMACY MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 12. GLOBAL EFFERVESCENT PRODUCTS BY ONLINE PHARMACY MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 13. GLOBAL EFFERVESCENT PRODUCTS BY RETAIL PHARMACY MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 14. GLOBAL EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY PRODUCT FORM, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY DISTIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 19. EUROPEAN EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. EUROPEAN EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY PRODUCT FORM, 2022-2030 ($ MILLION)
  • 21. EUROPEAN EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
  • 22. EUROPEAN EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 23. ASIA- PACIFIC EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 24. ASIA- PACIFIC EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY PRODUCT FORM, 2022-2030 ($ MILLION)
  • 25. ASIA- PACIFIC EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
  • 26. ASIA- PACIFIC EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY PRODUCT FORM, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY PRODUCT FORM, 2022 VS 2030 (%)
  • 2. GLOBAL EFFERVESCENT PRODUCTS AS TABLETS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL EFFERVESCENT PRODUCTS AS POWDER MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL EFFERVESCENT PRODUCTS AS GRANULES MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022 VS 2030 (%)
  • 6. GLOBAL EFFERVESCENT PRODUCTS FOR DIURETIC MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL EFFERVESCENT PRODUCTS FOR PAIN MANAGEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL EFFERVESCENT PRODUCTS FOR GASTRIC DISORDER MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL EFFERVESCENT PRODUCTS FOR RESPIRATORY DISORDER MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • 11. GLOBAL EFFERVESCENT PRODUCTS BY HOSPITAL PHARMACY MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • 12. GLOBAL EFFERVESCENT PRODUCTS BY ONLINE PHARMACY MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • 13. GLOBAL EFFERVESCENT PRODUCTS BY RETAIL PHARMACY MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • 14. GLOBAL EFFERVESCENT PRODUCTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. US EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. CANADA EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. UK EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. FRANCE EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. GERMANY EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. ITALY EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. SPAIN EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF EUROPE EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. INDIA EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. CHINA EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. JAPAN EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. SOUTH KOREA EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)